Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview

Mateo Porres-Aguilar, Jose T. Altamirano, Aldo Torre-Delgadillo, Michael R. Charlton, Andres Duarte-Rojo

Source: Eur Respir Rev 2012 21: 223-233
Journal Issue: September 2012 - 21 (125)
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mateo Porres-Aguilar, Jose T. Altamirano, Aldo Torre-Delgadillo, Michael R. Charlton, Andres Duarte-Rojo. Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview. Eur Respir Rev 2012 21: 223-233

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The lung in liver disease: hepatopulmonary syndrome and portopulmonary hypertension
Source: Eur Respir Monogr 2019; 86: 262-277
Year: 2019


The hepatopulmonary syndrome
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=112
Year: 2005

Liver transplantation in hepatopulmonary syndrome and portopulmonary hypertension
Source: Annual Congress 2003 - Pulmonary-hepatic disorders (PHD) - recommendations of the PHD ERS Task Force for management of hepatopulmonary syndrome and portopulmonary hypertension
Year: 2003

Portopulmonary hypertension
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=129
Year: 2005

Association between portopulmonary hypertension and hepatopulmonary syndrome in cirrhotics, candidates to hepatic transplantation
Source: Annual Congress 2003 - Pulmonary hypertension
Year: 2003


An autopsy case of portopulmonary hypertension associated with idiopathic portal hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Hepatopulmonary syndrome among patients of cirrhosis of liver and portal hypertension
Source: Annual Congress 2007 - Pulmonary circulation
Year: 2007


Portopulmonary hypertension: a further clue to pathogenesis?
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005

Hepatopulmonary syndrome following portopulmonary hypertension
Source: Eur Respir J 2007; 29: 1277-1280
Year: 2007



Development of hepatopulmonary syndrome during combination therapy for portopulmonary hypertension
Source: Eur Respir J, 53 (1) 1801880; 10.1183/13993003.01880-2018
Year: 2019



Resolution of portopulmonary hypertension (POPH) following liver transplantation
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012

Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension
Source: Eur Respir J 2004; 24 : 703-707
Year: 2004



How should we treat portopulmonary hypertension?
Source: Eur Respir J 2006; 28: 466-467
Year: 2006


Portopulmonary hypertension
Source: Virtual Congress 2021 – Pulmonary vascular diseases
Year: 2021


The metabolic syndrome and pulmonary hypertension
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020


Sildenafil for patients with portopulmonary hypertension, candidates to hepatic transplant
Source: Eur Respir J 2004; 24: Suppl. 48, 109s
Year: 2004

Experience with inhaled iloprost and bosentan in portopulmonary hypertension
Source: Eur Respir J 2007; 30: 1096-1102
Year: 2007



Portopulmonary hypertension: a consequence of portal hypertension
Source: Eur Respir Mon 2012; 57: 58-70
Year: 2012